Use of Diabetes Medications before and after a Heart Failure-Related Hospitalization among Nursing Home Residents.

ABSTRACT:

Objectives

Sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiovascular benefits, whereas thiazolidinediones (TZDs) and sulfonylureas (SUs) increase cardiovascular risk. The objective of this study was to describe the use of SGLT-2is, GLP-1RAs, TZDs, and SUs before and after a heart failure (HF)-related hospitalization in nursing home (NH) residents with type 2 diabetes (T2D).

Design

This was a cohort study using a 20% sample of Medicare claims linked with Minimum Data Set resident assessments.

Setting and participants

The study population was long-stay NH residents with T2D and an HF-related hospitalization between January 1, 2013, and August 31, 2018. For individuals with multiple HF hospitalizati

SUBMITTER: Zhang T 

PROVIDER: S-EPMC10839110 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature